Aidan's Law
Official title: To amend the Public Health Service Act, in relation to requiring adrenoleukodystrophy screening of newborns.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the House Committee on Energy and Commerce.
Aidan's Law
This bill authorizes newborn screenings for adrenoleukodystrophy (also known as ALD), which is a hereditary condition that damages the insulating membrane of nerve cells in the brain. The bill authorizes hospitals, child care centers, clinics, and similar institutions to test newborns for ALD in accordance with state protocols; such protocols must be approved by the Discretionary Advisory Committee on Heritable Disorders in Newborns and Children.
The bill also reauthorizes through FY2022 the heritable disorders screening program for newborns and children that is administered by the Health Resources and Services Administration.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 5453: Aidan's Law. 115th Congress. Open America. https://openamerica.io/bill/115-HR-5453/
"H.R. 5453: Aidan's Law." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-5453/.
H.R. 5453, 115th Cong. (2026), https://openamerica.io/bill/115-HR-5453/.
[H.R. 5453: Aidan's Law](https://openamerica.io/bill/115-HR-5453/)